Cerenome (PSTV) Operating Leases (2019 - 2025)
Plus Therapeutics (PSTV) posted quarterly Operating Leases of $15000.0 for Q4 2025, down 51.61% year-over-year from $31000.0 in Q4 2024, and down 51.61% quarter-over-quarter from $31000.0 in Q4 2024.
Cerenome (PSTV) Operating Leases (2019 - 2025) Analysis & Trends
Plus Therapeutics (PSTV) has reported Operating Leases for 7 consecutive years, with $15000.0 the latest figure, recorded in Q4 2025.
- In Q4 2025, Operating Leases fell 51.61% year-over-year to $15000.0; the TTM figure through Dec 2025 stood at $15000.0 (down 51.61% YoY), while the FY2025 annual figure was $15000.0, down 51.61% from the prior year.
- Operating Leases slipped to $15000.0 in Q4 2025 per PSTV's latest filing, from $31000.0 in the prior quarter.
- Across five years, Operating Leases topped out at $530000.0 in Q2 2021 and bottomed at $15000.0 in Q4 2025.
- Historically, Operating Leases has averaged $186470.6 across 5 years, with a median of $136000.0 in 2023.
- Annual changes were most pronounced in 2021 — Operating Leases decreased 7.52% — and 2024, when it slumped 66.1%.
- Plus Therapeutics' Operating Leases stood at $269000.0 in 2021, then slumped by 47.58% to $141000.0 in 2022, then slumped by 39.72% to $85000.0 in 2023, then sank by 63.53% to $31000.0 in 2024, then slumped by 51.61% to $15000.0 in 2025.
- Business Quant data shows PSTV's Operating Leases at $15000.0 in Q4 2025, $31000.0 in Q4 2024, and $40000.0 in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.40 Bn | 131.54 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.13 Bn | 78.13 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.58 Bn | 60.40 Bn | 1.37 Bn |
| 4 | Moderna | 58.23 Bn | 53.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.18 Bn | 37.08 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.61 Bn | 28.30 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.97 Bn | 9.58 Bn | 668.28 Mn |
| 8 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.31 Bn | 26.47 Bn | - |
| 10 | Cerenome | 28.07 Mn | 19.48 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 15,000.00 |
| Dec 31, 2024 | 31,000.00 |
| Sep 30, 2024 | 40,000.00 |
| Jun 30, 2024 | 50,000.00 |
| Mar 31, 2024 | 59,000.00 |
| Dec 31, 2023 | 85,000.00 |
| Sep 30, 2023 | 118,000.00 |
| Jun 30, 2023 | 136,000.00 |
| Mar 31, 2023 | 80,000.00 |
| Dec 31, 2022 | 141,000.00 |
| Sep 30, 2022 | 172,000.00 |
| Jun 30, 2022 | 202,000.00 |
| Mar 31, 2022 | 235,000.00 |
| Dec 31, 2021 | 269,000.00 |
| Sep 30, 2021 | 504,000.00 |
| Jun 30, 2021 | 530,000.00 |
| Mar 31, 2021 | 503,000.00 |
| Dec 31, 2020 | 528,000.00 |
| Sep 30, 2020 | 545,000.00 |
| Jun 30, 2020 | 589,000.00 |